Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4

Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4

Ovarian cancer (OC) is the most lethal gynaecologic malignancy, attributed to its insidious growth, non-specific symptoms and late presentation. Unfortunately, current screening modalities are inadequate at detecting OC and many lack the appropriate specificity and sensitivity that is desired from a...

Full description

Bibliographic Details
Main Authors: Aruni Ghose, Lucy McCann, Shania Makker, Uma Mukherjee, Sri Vidya Niharika Gullapalli, Jayaraj Erekkath, Stephanie Shih, Ishika Mahajan, Elisabet Sanchez, Mario Uccello, Michele Moschetta, Sola Adeleke, Stergios Boussios
Format: Article
Language:English
Published: SAGE Publishing 2024-02-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/17588359241233225

Internet

https://doi.org/10.1177/17588359241233225

Similar Items